Literature DB >> 8578732

Human parvovirus B19 infection in blood donors.

M Tsujimura1, K Matsushita, H Shiraki, H Sato, K Okochi, Y Maeda.   

Abstract

Using an immunodiffusion assay, we tested all of the blood units donated at the Fukuoka Red Cross Blood Center from June 1991 to July 1994 for B19 antigen. Over this 3-year trial period, we detected 16 viremic cases out of approximately 560,000 blood donors. Interestingly, most of the viremic donors (15 out of 16) were detected between February 1992 and January 1993, which coincided with a local erythema infectiosum epidemic in the Fukuoka area (December 1991 to August 1992). In particular, we detected 4 cases of viremia in March 1992, which was the peak of the erythema infectiosum epidemic. The incidence of B19 viremia in this peak period was approximately 1/4,000. The viremic donors ranged in age from 17 to 45 years, and most (11/16) were between 31 and 39 years old. By ELISA, using virus particles purified from viremic donor plasma as antigen, we analyzed the prevalence of B19-specific antibody among blood donors. The antibody-positive rate was approximately 40% in donors 16-30 years old, gradually increased in middle age, and reached a peak of 92% in donors more than 61 years old.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578732     DOI: 10.1111/j.1423-0410.1995.tb02595.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  12 in total

1.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

Review 2.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

3.  Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.

Authors:  Erik D Heegaard; Bodil Laub Petersen; Carsten J Heilmann; Allan Hornsleth
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2009-09

5.  Identification and characterization of persistent human erythrovirus infection in blood donor samples.

Authors:  Daniel Candotti; Nermin Etiz; Armen Parsyan; Jean-Pierre Allain
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 6.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

8.  Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan.

Authors:  Rika Endo; Nobuhisa Ishiguro; Hideaki Kikuta; Shinobu Teramoto; Reza Shirkoohi; Xiaoming Ma; Takashi Ebihara; Hiroaki Ishiko; Tadashi Ariga
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

9.  Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors.

Authors:  Rabab Hasanain Ahmed Hasanain; Rania M Saleh; Fadia M Attia; Hanaa H Gomaa
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-22       Impact factor: 0.900

Review 10.  Transfusion transmitted diseases.

Authors:  N Choudhury; S Phadke
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.